Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
175631756317563
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several …
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several … Continue reading "Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid"
The April issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, features, and case reports, with topics ranging from hormonal therapy in hidradenitis suppurativa, private equity in dermatology, vitiligo and its associated comorbidities, novel topical products for facial dyschromia, and many more. Check out this month’s issue highlights straight … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Eva Kerby, assistant professor of clinical dermatology at Weill Cornell Medical College. Dr. Kerby shares her preferred medical treatment options for keloids, and why it’s important to set treatment expectations with patients. Watch as Dr. Kerby shares tips for good injection technique and how to treat larger, nodul … 
The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation of a photonumeric scale … 
Wow! The ODAC Dermatology Conference in January 2022 highlighted the importance of conference attendance and the need for expert lectures on clinically relevant dermatologic topics. We are in an era when basic sciences and translational research has direct correlation and impact on our therapeutic measures for patients. While it is refreshing to have so many options for patients’ treatment, it … 